OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021

Predicting survival in NSCLC patients with poor performance status in resource-constrained settings

OncoAlert and ecancer weekly round up for July 19 - July 25, 2021

Part 3: How to test

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer

Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer

ASCO 2021: Precision and molecular reporting for prostate cancer

JAVELIN Bladder 100: Avelumab first-line maintenance plus best supportive care (BSC) versus BSC alone for advanced UC

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma

Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC